The Recall Desk
SevereFDA (Devices)·Z-0333-2023·Announced 2022-12-14

Gram-negative antibiotic susceptibility test device recalled for false susceptible results

Sensititre MDRGN3F antibiotic test device may return false susceptible results for certain gram-negative bacteria, risking inappropriate antibiotic treatment. FDA Class I recall issued.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I medical device recall without reported serious injury or death. The device may produce incorrect antibiotic susceptibility test results that could impact clinical treatment decisions.

Plain-English summary

The Sensititre MDRGN3F is an in vitro diagnostic device manufactured by Remel Inc used for antibiotic susceptibility testing of gram-negative bacteria.

An internal technical investigation confirmed the device may produce false susceptible results when testing bacteria from the Proteae Tribe (including Proteus species, Providencia species, and Morganella Morganii) against doripenem, ertapenem, meropenem, imipenem, cefepime, piperacillin/tazobactam, and aztreonam. This means organisms resistant to these antibiotics may be reported as susceptible.

The recall affects 70 units distributed nationwide (lot B2311B).

False susceptible results could lead to inappropriate antibiotic treatment selection, potentially compromising patient outcomes.

The recalled product

Product
Thermo SCIENTIFIC, Sensititre MDRGN3F, Gram Negative IVD AST
Manufacturer
Remel Inc
Hazard
  • false-susceptible-result
  • antibiotic-test-error

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot Numbers: B2311B

Distribution

Distributed nationwide across the United States.